Production and analysis of recombinant human proteins
Human proteins were used for crystallographic analyses and for interaction studies ( fig. S2) and activity assays ( fig. S6 ) that involved the isolated Brr2 N-terminal cassette, as the Nterminal cassette of yeast Brr2 could not be produced in soluble form. A DNA fragment encoding hPrp8
Jab1 (residues 2064-2335) was PCR-amplified using a synthetic gene encoding hPrp8 as a template and cloned into the BamHI and XhoI sites of pGEX-6P-1 (GE Healthcare).
The GST-hPrp8 Jab1 -encoding region was subcloned into EcoRI and HindIII sites of a pFL vector (22) . An expression construct for hPrp8 Jab1-ΔC15 was obtained by introduction of a stop codon via the QuikChange protocol (Stratagene). All proteins were produced in insect cells as described previously (18) .
For purification of hPrp8 Jab1 , the cell pellet was resuspended in 50 mM Tris-HCl, pH 8.0, 300 mM NaCl, 1 mM DTT, 5 % glycerol, 0.05 % NP-40, supplemented with protease inhibitors (Roche) and DNase I. Cells were lyzed by sonication using a Sonopuls Ultrasonic Homogenizer HD 3100 (Bandelin) and centrifuged for 1h at 53000 x g. The cleared lysate was loaded onto a Glutathione-Sepharose 4B resin (GE Healthcare) equilibrated with buffer A (50 mM Tris-HCl, pH 8.0, 300 mM NaCl, 1 mM DTT, 5% glycerol), incubated for 1h and eluted with buffer A plus 10 mM reduced glutathione. The sample was buffer-exchanged using a HiPrep 26/60 desalting column (GE Healthcare) equilibrated with buffer A and the GST-hPrp8 Jab1 fragment was cleaved overnight at 4°C with PreScission protease. The cleaved protein was loaded again on the affinity resin to remove uncleaved protein, GST and the protease. The flow-through was combined with purified hBrr2 HR in a 2:1 (hPrp8 were produced and purified following previously described protocols (18) . To monitor interaction of hPrp8 Jab1 with the various hBrr2 constructs, proteins were mixed with a two-fold molar excess of hPrp8 Jab1 and analytical gel filtration chromatography was carried out on a Superdex 200 PC 3.2/30 column (GE Healthcare) in 20 mM Tris-HCl, pH 8.0, 200 mM NaCl, 1 mM DTT.
Production and analysis of recombinant yeast proteins
Yeast proteins were used for the majority of functional assays as they are highly homologous to their human counterparts. Furthermore, RP13-linked Prp8 residues are highly conserved across evolution (Fig. 3A ) and the severity of retinal degeneration in patients with RP13
mutations correlates with the severity of growth phenotypes associated with corresponding Prp8 mutations in haploid yeast (10) . yPrp8 Jab1 (residues 2012-2413) and mutant/truncated versions thereof, were produced in E. coli and purified as described previously (12, 20) . Site-directed mutations were introduced via the QuikChange protocol and were verified by sequencing. Fulllength yBrr2 containing an N-terminal His 6 -tag was produced in yeast INVSc1 cells (Invitrogen) and purified as described (13) . To monitor interaction of yBrr2 with yPrp8 Jab1 variants, equimolar amounts (4 µM each) of the proteins were mixed and incubated for 30 min at 4 °C in 50 µl reaction volume, and size exclusion chromatography was subsequently performed with a Superdex 200 PC 3.2/30 column in 40 mM Tris-HCl, pH 7.5, 100 mM NaCl, 2 mM DTT, 5 % glycerol.
Crystallographic analyses
The hBrr2 HR -hPrp8 Jab1 complex was concentrated to 12 mg/ml and crystallized at 4 ºC using the hanging drop vapor diffusion method. Crystals were obtained by mixing 1 µl of protein solution with 0. (16) as search models. The structure was refined through several rounds of manual model building in COOT (25) and restrained refinement in PHENIX (26) .
RNA binding studies
His-tag pulldown assays were performed as described previously (13) , except His-tagged yBrr2 (0.8 µM) and yPrp8 Jab1 or yPrp8 Jab1-ΔC16 (3 µM) were first combined, followed in some cases by 2 mM ATPγS, and then [ 32 P]-labeled U4/U6 di-snRNA (a mixture of 5 nM labeled and 15 nM non-labeled RNA) was added. Fluorescence anisotropy was performed essentially as described (18) , except a FAM-5' end-labeled, 24 nt single-stranded RNA (5 nM) was incubated in the presence of 0-400 nM yBrr2 alone or yBrr2 pre-incubated with 1 µM yPrp8 Jab1 or yPrp8 Jab1-ΔC16 followed by addition of 1 mM ATPγS where indicated. The apparent equilibrium dissociation constants (K d ) for Brr2-RNA complex formation were determined as previously described (18) .
ATPase and U4/U6 di-snRNA unwinding assays
Steady-state ATPase assays were performed as described (18) . Briefly, 25 nM yBrr2, 0.5 µM U4/U6 di-snRNA, 0.5 mM ATP and, where indicated, 1 µM of yPrp8 Jab1 variants were mixed at 20 °C, and the amount of liberated inorganic phosphate was measured using a malachite dyebased kit (PiColorLock™ Gold, Innova Biosciences).
U4/U6 di-snRNA unwinding assays were carried out at 20 °C or 30 °C for 0-50 min essentially as described (18), except helicases were incubated alone or with 0.75 µM of yPrp8 Jab1 or mutants thereof for 15 min at 4 °C prior to addition of RNA. In all experiments, U4 snRNA was radiolabeled. RNA duplex displacement was analyzed by 6 % native PAGE, visualized by autoradiography and quantified as described (20) . Reannealing of the U4/U6 duplex after strand displacement is not observed under these assay conditions due to the formation of a U6 intra-molecular stem-loop that precludes U4/U6 duplex formation.
To determine the specificity of the yPrp8 Jab1 effects, 200 nM yBrr2 or 150 nM yPrp22 were pre-incubated with increasing concentrations (0-2 µM) of yPrp8
Jab1
. U4/U6 duplex (0.5 nM) was 
Analysis of tri-snRNP levels in yeast cells
Total cell extract was prepared from yeast cells grown at 30°C that express wt Prp8 or the indicated Prp8 temperature sensitive mutant (29) . Extracts were incubated at 35°C (i.e., the non-permissive temperature for the Prp8 temperature sensitive mutants) for 20 min and then subjected to 10-30% glycerol gradient centrifugation as described (21) . RNA from every second gradient fraction was isolated and the distribution of the spliceosomal snRNAs was analyzed by
Northern blotting with [ superimposed on the human Prp8 Jab1 domain (gold) in complex with hBrr2 HR (grey semitransparent surface). The structure of isolated hPrp8 Jab1 is not available but most likely closely resembles those of yeast and C. elegans Prp8 Jab1 due to the high sequence similarity of these proteins. The structure of hPrp8 Jab1 in complex with hBrr2 HR is similar to the structure of isolated yPrp8 Jab1 (rmsd of 1.48 Å for 226 Cα atoms) and C. elegans Prp8 Jab1 (rmsd of 1.00 Å for 238 Cα atoms), with significant deviations only in elements that directly contact hBrr2 HR (circled).
Additionally, the C-terminal tail of the Jab1 domain was flexible and only partially resolved in the , and
Brr2 association was not affected. Thus, the in vivo effects of these mutations, which based on our structure are expected to destabilize the interaction of Prp8's tail with Brr2, can be attributed to misregulation of Brr2 during splicing, rather than a defect in U5 or tri-snRNP formation. (D)
Interaction of various yPrp8 Jab1 mutants with yBrr2 monitored by gel filtration. Seven identical fractions were analyzed. Numbers on the left, molecular mass standards in kD. 
